| 1 |
Ponikowski P, Voors AA, Anker SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure ：The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J]．Eur Heart J，2016，37(27):2129-2200.
|
| 2 |
Johnson FL.Pathophysiology and etiology of heart failure[J]．Cardiol Clin，2014，32(1):9-19.
|
| 3 |
POISE Study Group, Devereaux PJ, Yang H, et al.Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial)：a randomised controlled trial[J]．Lancet，2008，371(9627):1839-1847.
|
| 4 |
梁健球．关于心肌梗死后心力衰竭患者血浆中miRNA表达及基于ECHO的心肌能量消耗的研究[D]．广州：南方医科大学，2013.
|
| 5 |
Zhao DS, Chen Y, Jiang H, et al.Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure[J]．Cardiovasc Pathol，2013，22(6):444-450.
|
| 6 |
Vogel B, Keller A, Frese KS, et al.Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure[J]．Eur Heart J，2013，34(36):2812-2823.
|
| 7 |
Tijsen AJ, Creemers EE, Moerland PD, et al.MiR423-5p as a circulating biomarker for heart failure[J]．Circ Res，2010，106(6):1035-1039.
|
| 8 |
Ellis KL, Cameron VA, Troughton RW, et al.Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients[J]．Eur J Heart Fail，2013，15(10):1138-1147.
|
| 9 |
Goren Y, Kushnir M, Zafrir B, et al.Serum levels of microRNAs in patients with heart failure[J]．Eur J Heart Fail，2012，14(2):147-154.
|
| 10 |
Fan KL, Zhang HF, Shen J, et al.Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy[J]．Indian Heart J，2013，65(1):12-16.
|
| 11 |
谈红，李艳敏，张红明，等．慢性充血性心力衰竭患者血浆miR-423-5p和miR-210-3p的表达变化[J]．临床心血管病杂志，2014，30(12):1081-1085.
|
| 12 |
王秀芝，徐东杰．血清微小RNA-21-5p表达量预测急性心力衰竭患者近期预后的价值[J]．江苏医药，2015，41(16):1931-1933.
|
| 13 |
Watson CJ, Gupta SK, O’Connell E, et al.MicroRNA signatures dif-ferentiate preserved from reduce ejection fraction heart failure[J]．Eur J Heart Fail，2015，17(4):405-415.
|
| 14 |
Ellis KL, Cameron VA, Troughton RW, et al.Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients[J]．Eur J Heart Fail，2013，15(10):1138-1147.
|